Afayro 40mg Tablet is a medication containing the active ingredient Apremilast. Apremilast is a phosphodiesterase 4 (PDE4) inhibitor. PDE4 is an enzyme found in inflammatory cells, and inhibiting it helps to reduce the production of certain proteins that cause inflammation in the body. This anti-inflammatory action makes Afayro effective in managing specific chronic inflammatory conditions.
Afayro 40mg Tablet is primarily indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adult patients who have had an inadequate response or intolerance to other therapies. It is also used for the treatment of oral ulcers in adult patients with Behçet’s disease.
The typical dosage for Afayro 40mg Tablet involves a titration schedule to minimize gastrointestinal side effects. Patients usually start with lower doses and gradually increase to the maintenance dose of 40mg twice daily. It is important to take the medication as prescribed by your healthcare provider. Do not crush, chew, or break the tablet; swallow it whole.
Common side effects may include diarrhea, nausea, headache, and upper respiratory tract infections. If you experience any severe or persistent side effects, consult your doctor immediately. Afayro 40mg Tablet should be stored at room temperature, away from moisture and heat. Keep out of reach of children.
